Zhao, Xiao http://orcid.org/0000-0002-4504-5670
Zhao, Ruifang
Nie, Guangjun http://orcid.org/0000-0001-5040-9793
Article History
Received: 17 October 2021
Accepted: 21 April 2022
First Online: 25 July 2022
Competing interests
: G.N. and X.Z. are inventors on a filed provisional application China patent no. CN202011407688.7 (Bacterial outer membrane vesicle, a general nanovaccine containing bacterial outer membrane vesicle, preparation method and application thereof), submitted by the National Center for Nanoscience and Technology that covers the potential diagnostic and therapeutic uses of OMV-based nanovaccine for cancer immunotherapy. G.N. and R.Z. are inventors on a filed provisional application China patent no. CN202010418720.5 (Nanovaccine to prevent cancer recurrence), submitted by the National Center for Nanoscience and Technology that covers the potential diagnostic and therapeutic uses of HM-NP vaccine for cancer immunotherapy. The authors declare that they have no other competing interests.
Free to read: This content has been made available to all.